Regular short-acting β2-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring.

Saved in:
Bibliographic Details
Title: Regular short-acting β2-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring.
Authors: Csonka LL; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Electronic address: leon.csonka@tuni.fi., Vähätalo I; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland., Ilmarinen P; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland., Tuomisto LE; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland., Kankaanranta H; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland; Krefting Research Centre, Institute of Medicine, Dept of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Lehtimäki L; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Allergy Centre, Tampere University Hospital, Tampere, Finland.
Source: Heart & lung : the journal of critical care [Heart Lung] 2026 Apr 14; Vol. 79, pp. 102789. Date of Electronic Publication: 2026 Apr 14.
Publication Type: Journal Article
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0330057 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3288 (Electronic) Linking ISSN: 01479563 NLM ISO Abbreviation: Heart Lung Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3288
DOI:10.1016/j.hrtlng.2026.102789